Johnson & Johnson (JNJ) Stock Price, Quote & News

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 732 524 0400

Website: www.jnj.com

Address:

One Johnson & Johnson Plaza, New Brunswick, United States

yellowstar16 Aug. 19 at 12:14 PM

$JNJ Ride MRNA draft. Will lift whole sector today. Cancer cure is right up JnJ alley. This may be the start of something wonderful.

0 · Reply

Imr77 Aug. 19 at 11:32 AM

$SLS $JNJ better hurry up with the offer😉 or you will be left behind by $MRK

0 · Reply

LorriPurdy207 Aug. 19 at 9:13 AM

$JNJ $BE $KOLD $KHC Johnson & Johnson provides diversified healthcare exposure, Bloom Energy benefits from data-center power demand, KOLD provides leveraged inverse natural-gas exposure, and Kraft Heinz remains tied to consumer staples demand. I'm watching healthcare demand, power contracts, natural-gas prices, pricing, and volumes.

0 · Reply

DeanPresto849 Aug. 19 at 7:15 AM

0 · Reply

RockyTSTH Aug. 19 at 4:59 AM

$JNJ - Stock close to all time highs . Strong uptrend pattern holding up. calls looking good as long as $270 holds for a move towards $285 and $300. high watch here

0 · Reply

iMake_Moves Aug. 19 at 4:08 AM

$JNJ never thought I’d say this….. But Johnson & Johnson looks like a good short right now

0 · Reply

Techdamentals Aug. 19 at 3:16 AM

$JNJ Breaking out and look at that volume....

0 · Reply

parcha Aug. 18 at 10:03 PM

$VHT $XLV $LLY $JNJ Health care, biotech stocks climb to all-time highs Tuesday Health care and biotechnology stocks climbed to all-time highs Tuesday as investors searched for pockets of strength in the market beyond tech. The $44 billion State Street Health Care Select Sector SPDR ETF, made up of 62 stocks, reached a record. The fund’s total return over the past three months, including reinvested dividends, is 15.6% versus 4.8% for the S&P 500. The fund consists of 62 stocks, with Eli Lilly and Johnson & Johnson comprising 26% of the portfolio. The $19 billion Vanguard Health Care Index Fund also rose to a record, bringing its three-month total return to 16.6%. The fund contains 415 stocks and Lilly and J&J take up 22.2% of the total. https://www.cnbc.com/2026/08/17/stock-market-today-live-updates.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension

0 · Reply

parcha Aug. 18 at 10:00 PM

$JNJ Shares of Johnson & Johnson rose more than 3% in afternoon trading Tuesday, heading for a fresh closing record. If that move higher holds through the close, it would mark the stock’s first record close since July 7, when it gained 3.1% to $267.24. The stock has gained roughly 31% year to date, more than double the S&P 500′s advance in the same period.

0 · Reply

Ryuk Aug. 18 at 8:19 PM

$JNJ $260 by Friday. Trash. 💩

0 · Reply

Oppenheimer upgrades Intuitive Surgical on lack of U.S. competition

ISRG

Aug 13, 2026, 11:15 PM EDT - 5 days ago

Expert explains why healthcare is a top-performing sector

ABBV AMGN BIIB GILD LLY MRK UNH

Aug 10, 2026, 4:27 PM EDT - 8 days ago

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

2026-08-07T19:33:43.000Z - 11 days ago

3 ‘Strong Buy’ Dividend Aristocrat Stocks to Grab Right Now to Get Paid in September — 8/7/26

CVX WMT

Aug 6, 2026, 6:23 PM EDT - 12 days ago

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

AMAT AXP COF CRWD GS KLAC LLY

2026-08-06T10:48:29.000Z - 13 days ago

Johnson & Johnson price target raised to $287 from $270 at Guggenheim

2026-08-05T18:48:12.000Z - 13 days ago

3 ‘Strong Buy’ Dividend Aristocrat Stocks for Dependable Income, 8/5/26

IBM KO

Aug 4, 2026, 4:05 PM EDT - 14 days ago

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

2026-08-04T12:50:51.000Z - 14 days ago

Johnson & Johnson announces Taubert to retire as EVP, Worldwide Chairman

Aug 4, 2026, 8:45 AM EDT - 14 days ago

Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

Aug 3, 2026, 8:00 AM EDT - 16 days ago

Johnson & Johnson Transcript: Investor update

2026-08-03T11:00:29.000Z - 16 days ago

Johnson & Johnson price target raised to $282 from $272 at Wells Fargo

2026-08-03T09:35:43.000Z - 16 days ago

Johnson & Johnson removed from US Conviction List at Goldman Sachs

Aug 2, 2026, 8:00 AM EDT - 17 days ago

Inside J&J's Lab to Create a Simpler Robotic Surgery Device

2026-07-30T12:35:46.000Z - 19 days ago

Johnson & Johnson’s head & neck cancer candidate granted FDA Priority Review

Jul 30, 2026, 8:30 AM EDT - 19 days ago

Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer

Jul 29, 2026, 6:13 PM EDT - 20 days ago

Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines

Jul 29, 2026, 5:42 PM EDT - 20 days ago

Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation

Jul 29, 2026, 5:38 PM EDT - 20 days ago

Johnson & Johnson lowers 2026 profit forecast

Jul 29, 2026, 5:28 PM EDT - 20 days ago

Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset

Jul 29, 2026, 12:01 PM EDT - 20 days ago

Explainer: Can J&J finally put the talc litigation behind it?

Jul 28, 2026, 4:31 PM EDT - 21 days ago

Johnson & Johnson offers $5.5 billion to settle remaining lawsuits over talc products linked to cancer

Jul 28, 2026, 12:26 PM EDT - 21 days ago

Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits

Jul 28, 2026, 1:03 AM EDT - 22 days ago

Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit

Jul 28, 2026, 12:31 AM EDT - 22 days ago

J&J offers $5.5bn to settle baby powder lawsuits

Jul 27, 2026, 9:29 PM EDT - 22 days ago

Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits

Jul 27, 2026, 6:47 PM EDT - 22 days ago

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

Jul 27, 2026, 6:31 PM EDT - 22 days ago

Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation

Jul 27, 2026, 5:45 AM EDT - 23 days ago

Robert Kiyosaki sees a brutal depression ahead: 3 stocks that may protect portfolios

NEM WMT

$TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma$

Jul 23, 2026, 8:30 AM EDT - 26 days ago

TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma

Jul 22, 2026, 4:33 PM EDT - 27 days ago

US judge casts doubt on 69,000 cases alleging J&J talc caused cancer

Jul 22, 2026, 7:21 AM EDT - 4 weeks ago

Johnson & Johnson's robotic surgery device gets US FDA marketing authorization

Jul 22, 2026, 7:00 AM EDT - 4 weeks ago

Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System

Jul 21, 2026, 6:30 PM EDT - 4 weeks ago

Jim Cramer says this old-school investing concept still wins — even in the AI boom

BNY CVS GS MMM WFC

Jul 16, 2026, 8:11 AM EDT - 4 weeks ago

Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award

Jul 16, 2026, 8:00 AM EDT - 4 weeks ago

DePuy Synthes Acquires Expanding Innovations™

Jul 15, 2026, 12:09 PM EDT - 4 weeks ago

J&J Leverages AI and Robots to Target $100 Billion in Annual Revenue

Jul 15, 2026, 8:30 AM EDT - 4 weeks ago

Johnson & Johnson Earnings Call Transcript: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 4 weeks ago

Johnson & Johnson Slides: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 4 weeks ago

Johnson & Johnson Earnings release: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 4 weeks ago

Johnson & Johnson Quarterly report: Q2 2026

Jul 15, 2026, 7:27 AM EDT - 5 weeks ago

ASML, Intel, Johnson & Johnson, and More Stocks That Explain Today's Market

ASML INTC

Jul 15, 2026, 6:35 AM EDT - 5 weeks ago

Johnson & Johnson Hikes Guidance, Stock Falls

Jul 15, 2026, 6:33 AM EDT - 5 weeks ago

Johnson & Johnson Bumps Up Guidance as Sales Rise

Jul 15, 2026, 6:25 AM EDT - 5 weeks ago

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026

Jul 15, 2026, 6:23 AM EDT - 5 weeks ago

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Jul 15, 2026, 6:20 AM EDT - 5 weeks ago

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

Jul 9, 2026, 1:00 PM EDT - 5 weeks ago

The Big 3: UNH, KO, JNJ

KO UNH

Jul 8, 2026, 7:45 AM EDT - 6 weeks ago

Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform

Jul 6, 2026, 6:29 PM EDT - 6 weeks ago

Jim Cramer says these are the 5 stocks to buy during this market rotation

PEP SBUX STZ TJX

Jun 26, 2026, 2:39 PM EDT - 7 weeks ago

Healthcare stocks have become a haven for investors ditching tech

ABBV ABSI APGE LLY MRNA SNY XBI

Jun 26, 2026, 12:35 PM EDT - 7 weeks ago

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

Jun 25, 2026, 5:00 AM EDT - 7 weeks ago

Johnson & Johnson Advances Cardiac Ablation Technology in Europe with Availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform

Jun 15, 2026, 6:00 AM EDT - 2 months ago

Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida

$New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma$

Jun 13, 2026, 6:41 AM EDT - 2 months ago

New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

$New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma$

Jun 13, 2026, 6:33 AM EDT - 2 months ago

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma

Jun 11, 2026, 7:45 AM EDT - 2 months ago

Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients

Jun 11, 2026, 2:03 AM EDT - 2 months ago

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies

Jun 10, 2026, 11:22 AM EDT - 2 months ago

Johnson & Johnson Hit with $32 Million Verdict in Los Angeles Asbestos Trial

Jun 10, 2026, 6:20 AM EDT - 2 months ago

Johnson & Johnson CEO Says Cure for Certain Cancers Is Realistic Goal

Jun 9, 2026, 10:00 AM EDT - 2 months ago

Johnson & Johnson Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN LLY MRK NVO PFE

Jun 8, 2026, 9:01 AM EDT - 2 months ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion

yellowstar16 Aug. 19 at 12:14 PM

$JNJ Ride MRNA draft. Will lift whole sector today. Cancer cure is right up JnJ alley. This may be the start of something wonderful.

0 · Reply

Imr77 Aug. 19 at 11:32 AM

$SLS $JNJ better hurry up with the offer😉 or you will be left behind by $MRK

0 · Reply

LorriPurdy207 Aug. 19 at 9:13 AM

0 · Reply

DeanPresto849 Aug. 19 at 7:15 AM

0 · Reply

RockyTSTH Aug. 19 at 4:59 AM

$JNJ - Stock close to all time highs . Strong uptrend pattern holding up. calls looking good as long as $270 holds for a move towards $285 and $300. high watch here

0 · Reply

iMake_Moves Aug. 19 at 4:08 AM

$JNJ never thought I’d say this….. But Johnson & Johnson looks like a good short right now

0 · Reply

Techdamentals Aug. 19 at 3:16 AM

$JNJ Breaking out and look at that volume....

0 · Reply

parcha Aug. 18 at 10:03 PM

0 · Reply

parcha Aug. 18 at 10:00 PM

0 · Reply

Ryuk Aug. 18 at 8:19 PM

$JNJ $260 by Friday. Trash. 💩

0 · Reply

kiwiSurfer Aug. 18 at 7:48 PM

$LEGN $LEGN and $JNJ showing Bullish Massive Options Flow could it finally be happening?!!!

1 · Reply

HydrogenH2 Aug. 18 at 7:25 PM

$JNJ Enjoy the $$$ But don't forget that insiders are starting to trade it this month !! They know more about the value about the company than most "pumpers" on stocktwits !! lol

0 · Reply

PittsburghTrader Aug. 18 at 7:13 PM

$MRK $JNJ up strong today, why no luv for $MRK ?

1 · Reply

heikoscreens Aug. 18 at 5:55 PM

These are the current Dividend Aristocrats: $BDX $DOV $EMR $GWW $JNJ ...

1 · Reply

TechniTraderEducation Aug. 18 at 5:52 PM

Swing traders, this distinction can keep you from reacting to the wrong signal in $JNJ. When price declines on small candlesticks and falling volume, it may be a Void of Buyers—not panic selling. That tells you sellers are not necessarily taking control. How can you use this? • Avoid treating every price decline as bearish. • Check volume and Accumulation/Distribution for actual selling pressure. • Wait for evidence that buyers are returning before entering. • Recognize when corporate stock buybacks—not retail momentum—may be supporting price. These patterns are not automatic trade signals. They help you understand WHO is moving the stock so you can make a better swing-trading decision. See the patterns on the daily $JNJ stock chart: https://www.tradingview.com/chart/JNJ/K9SWWraO-Void-of-Buyers-vs-Corporate-Buyback-Patterns/ Trade wisely, Martha Stokes, CMT #SwingTrading #TechnicalAnalysis

0 · Reply

StageAnalysis Aug. 18 at 4:18 PM

Pharmaceuticals industry group is one of the strongest parts of the market currently Largest stocks in the group by weighting: $LLY, $JNJ, $MRK, $PFE, BMY, NVO, AZN, ZTS, NVS, AXSM, GSK, JAZZ, TEVA, RPRX, VTRS, SNY, ELAN, LQDA, DFTX, CORT, RHHBY, ELVN, TARS, NKTR, TAK, AMLX, SUPN, TRVI, RDY, PRGO, AMRX, OGN, PBH, HRMY, HROW, ANIP, OCUL, BHC, SEPN, INVA, MAZE, XERS, RAPP, LBRX, PAHC, CHGCY, GTBIF, MKKGY, TLX, HCM

1 · Reply

StockBraker Aug. 18 at 4:02 PM

$JNJ Don’t change that channel. 📺 👀

0 · Reply

HydrogenH2 Aug. 18 at 3:50 PM

$JNJ $AMGN $LLY and talking about Cramer ... "Cramer i'm not going to say that on tv !! " https://youtu.be/8DJlogbrDcA?t=74

0 · Reply

HydrogenH2 Aug. 18 at 3:46 PM

$JNJ $AMGN $LLY First Cantor Fitzgerald is this guy's family !! and always do opposite of Cramer's calls... here why... lol https://www.youtube.com/shorts/JTSl9Q38Ih0

0 · Reply

HydrogenH2 Aug. 18 at 3:43 PM

$JNJ

0 · Reply

HydrogenH2 Aug. 18 at 3:15 PM

$JNJ $ABBV I'm taking profits !! Thanks !!

0 · Reply

GettnFibbywIT Aug. 18 at 3:14 PM

$JNJ $XLV

0 · Reply

Market Cap	632.28B
Revenue (ttm)	94.19B
Net Income (ttm)	26.80B
EPS (ttm)	N/A
PE Ratio	23.97
Forward PE	22.42
Profit Margin	28.46%
Debt to Equity Ratio	0.44

Volume	7,838,100
Avg Vol	8,159,524
Day's Range	N/A - N/A
Shares Out	2.41B
Stochastic %K	96%
Beta	0.24
Analysts	Strong Sell
Price Target	$275.42